Frank C. Odds - Publications

Affiliations: 
School of Medical Sciences University of Aberdeen, Aberdeen, Scotland, United Kingdom 
Area:
Candida albicans, virulence, MLST, antifungals

183 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2015 Sandai D, Yin Z, Selway L, Stead D, Walker J, Leach MD, Bohovych I, Ene IV, Kastora S, Budge S, Munro CA, Odds FC, Gow NA, Brown AJ. Correction for Sandai et al., The Evolutionary Rewiring of Ubiquitination Targets Has Reprogrammed the Regulation of Carbon Assimilation in the Pathogenic Yeast Candida albicans. Mbio. 6. PMID 25604791 DOI: 10.1128/Mbio.02489-14  0.535
2014 Shahana S, Childers DS, Ballou ER, Bohovych I, Odds FC, Gow NA, Brown AJ. New Clox Systems for rapid and efficient gene disruption in Candida albicans. Plos One. 9: e100390. PMID 24940603 DOI: 10.1371/Journal.Pone.0100390  0.621
2013 Bates S, Hall RA, Cheetham J, Netea MG, MacCallum DM, Brown AJ, Odds FC, Gow NA. Role of the Candida albicans MNN1 gene family in cell wall structure and virulence. Bmc Research Notes. 6: 294. PMID 23886038 DOI: 10.1186/1756-0500-6-294  0.808
2013 Hall RA, Bates S, Lenardon MD, Maccallum DM, Wagener J, Lowman DW, Kruppa MD, Williams DL, Odds FC, Brown AJ, Gow NA. The Mnn2 mannosyltransferase family modulates mannoprotein fibril length, immune recognition and virulence of Candida albicans. Plos Pathogens. 9: e1003276. PMID 23633946 DOI: 10.1371/Journal.Ppat.1003276  0.798
2013 Shahana S, Mora-Montes HM, Castillo L, Bohovych I, Sheth CC, Odds FC, Gow NA, Brown AJ. Reporters for the analysis of N-glycosylation in Candida albicans. Fungal Genetics and Biology : Fg & B. 56: 107-15. PMID 23608318 DOI: 10.1016/J.Fgb.2013.03.009  0.613
2013 Gazvani R, Fowler PA, Coyne L, Odds FC, Gow NAR. Does Candida albicans play a role in the etiology of endometriosis? Journal of Endometriosis and Pelvic Pain Disorders. 5: 2-9. DOI: 10.5301/Je.2013.10919  0.343
2012 Sandai D, Yin Z, Selway L, Stead D, Walker J, Leach MD, Bohovych I, Ene IV, Kastora S, Budge S, Munro CA, Odds FC, Gow NA, Brown AJ. The evolutionary rewiring of ubiquitination targets has reprogrammed the regulation of carbon assimilation in the pathogenic yeast Candida albicans. Mbio. 3. PMID 23232717 DOI: 10.1128/Mbio.00495-12  0.607
2012 Lee KK, Maccallum DM, Jacobsen MD, Walker LA, Odds FC, Gow NA, Munro CA. Elevated cell wall chitin in Candida albicans confers echinocandin resistance in vivo. Antimicrobial Agents and Chemotherapy. 56: 208-17. PMID 21986821 DOI: 10.1128/Aac.00683-11  0.808
2011 Cheetham J, MacCallum DM, Doris KS, da Silva Dantas A, Scorfield S, Odds F, Smith DA, Quinn J. MAPKKK-independent regulation of the Hog1 stress-activated protein kinase in Candida albicans. The Journal of Biological Chemistry. 286: 42002-16. PMID 21994942 DOI: 10.1074/Jbc.M111.265231  0.736
2011 Mora-Montes HM, Netea MG, Ferwerda G, Lenardon MD, Brown GD, Mistry AR, Kullberg BJ, O'Callaghan CA, Sheth CC, Odds FC, Brown AJ, Munro CA, Gow NA. Recognition and blocking of innate immunity cells by Candida albicans chitin. Infection and Immunity. 79: 1961-70. PMID 21357722 DOI: 10.1128/Iai.01282-10  0.594
2011 Sheth CC, Hall R, Lewis L, Brown AJ, Odds FC, Erwig LP, Gow NA. Glycosylation status of the C. albicans cell wall affects the efficiency of neutrophil phagocytosis and killing but not cytokine signaling. Medical Mycology. 49: 513-24. PMID 21254968 DOI: 10.3109/13693786.2010.551425  0.645
2011 Castillo L, MacCallum DM, Brown AJ, Gow NA, Odds FC. Differential regulation of kidney and spleen cytokine responses in mice challenged with pathology-standardized doses of Candida albicans mannosylation mutants. Infection and Immunity. 79: 146-52. PMID 21059878 DOI: 10.1128/Iai.01004-10  0.813
2010 Walker CA, Gómez BL, Mora-Montes HM, Mackenzie KS, Munro CA, Brown AJ, Gow NA, Kibbler CC, Odds FC. Melanin externalization in Candida albicans depends on cell wall chitin structures. Eukaryotic Cell. 9: 1329-42. PMID 20543065 DOI: 10.1128/Ec.00051-10  0.629
2010 Meerpoel L, Heeres J, Backx LJ, Van der Veken LJ, Hendrickx R, Corens D, De Groot A, Leurs S, Van der Eycken L, Weerts J, Luyts P, Van Gerven F, Woestenborghs FA, Van Breda A, Oris M, ... ... Odds FC, et al. Synthesis and in vitro and in vivo antifungal activity of the hydroxy metabolites of saperconazole. Chemmedchem. 5: 757-69. PMID 20379992 DOI: 10.1002/Cmdc.201000040  0.334
2010 Mora-Montes HM, Bates S, Netea MG, Castillo L, Brand A, Buurman ET, Díaz-Jiménez DF, Jan Kullberg B, Brown AJ, Odds FC, Gow NA. A multifunctional mannosyltransferase family in Candida albicans determines cell wall mannan structure and host-fungus interactions. The Journal of Biological Chemistry. 285: 12087-95. PMID 20164191 DOI: 10.1074/Jbc.M109.081513  0.629
2010 MacCallum DM, Coste A, Ischer F, Jacobsen MD, Odds FC, Sanglard D. Genetic dissection of azole resistance mechanisms in Candida albicans and their validation in a mouse model of disseminated infection. Antimicrobial Agents and Chemotherapy. 54: 1476-83. PMID 20086148 DOI: 10.1128/Aac.01645-09  0.743
2010 Odds FC. Molecular phylogenetics and epidemiology of Candida albicans. Future Microbiology. 5: 67-79. PMID 20020830 DOI: 10.2217/fmb.09.113  0.311
2009 Calderone R, Odds FC, Boekhout T. Candida albicans: fundamental research on an opportunistic human pathogen. Fems Yeast Research. 9: 971-2. PMID 19845040 DOI: 10.1111/J.1567-1364.2009.00585.X  0.354
2009 Odds FC. In Candida albicans, resistance to flucytosine and terbinafine is linked to MAT locus homozygosity and multilocus sequence typing clade 1. Fems Yeast Research. 9: 1091-101. PMID 19799637 DOI: 10.1111/J.1567-1364.2009.00577.X  0.321
2009 Rodaki A, Bohovych IM, Enjalbert B, Young T, Odds FC, Gow NA, Brown AJ. Glucose promotes stress resistance in the fungal pathogen Candida albicans. Molecular Biology of the Cell. 20: 4845-55. PMID 19759180 DOI: 10.1091/Mbc.E09-01-0002  0.571
2009 MacCallum DM, Castillo L, Brown AJ, Gow NA, Odds FC. Early-expressed chemokines predict kidney immunopathology in experimental disseminated Candida albicans infections. Plos One. 4: e6420. PMID 19641609 DOI: 10.1371/Journal.Pone.0006420  0.792
2009 Borman AM, Linton CJ, Oliver D, Palmer MD, Szekely A, Odds FC, Johnson EM. Pyrosequencing analysis of 20 nucleotides of internal transcribed spacer 2 discriminates Candida parapsilosis, Candida metapsilosis, and Candida orthopsilosis. Journal of Clinical Microbiology. 47: 2307-10. PMID 19403763 DOI: 10.1128/Jcm.00240-09  0.317
2009 MacCallum DM, Castillo L, Nather K, Munro CA, Brown AJ, Gow NA, Odds FC. Property differences among the four major Candida albicans strain clades. Eukaryotic Cell. 8: 373-87. PMID 19151328 DOI: 10.1128/Ec.00387-08  0.818
2009 Walker LA, Maccallum DM, Bertram G, Gow NA, Odds FC, Brown AJ. Genome-wide analysis of Candida albicans gene expression patterns during infection of the mammalian kidney. Fungal Genetics and Biology : Fg & B. 46: 210-9. PMID 19032986 DOI: 10.1016/J.Fgb.2008.10.012  0.814
2008 Odds FC. Secreted proteinases and Candida albicans virulence. Microbiology (Reading, England). 154: 3245-6. PMID 18957578 DOI: 10.1099/Mic.0.2008/023671-0  0.401
2008 Jacobsen MD, Duncan AD, Bain J, Johnson EM, Naglik JR, Shaw DJ, Gow NA, Odds FC. Mixed Candida albicans strain populations in colonized and infected mucosal tissues. Fems Yeast Research. 8: 1334-8. PMID 18795958 DOI: 10.1111/J.1567-1364.2008.00438.X  0.602
2008 Brand A, Barnes JD, Mackenzie KS, Odds FC, Gow NA. Cell wall glycans and soluble factors determine the interactions between the hyphae of Candida albicans and Pseudomonas aeruginosa. Fems Microbiology Letters. 287: 48-55. PMID 18680523 DOI: 10.1111/J.1574-6968.2008.01301.X  0.66
2008 Jacobsen MD, Bougnoux ME, d'Enfert C, Odds FC. Multilocus sequence typing of Candida albicans isolates from animals. Research in Microbiology. 159: 436-40. PMID 18653318 DOI: 10.1016/J.Resmic.2008.05.003  0.353
2008 Jacobsen MD, Rattray AM, Gow NA, Odds FC, Shaw DJ. Mitochondrial haplotypes and recombination in Candida albicans. Medical Mycology. 46: 647-54. PMID 18608923 DOI: 10.1080/13693780801986631  0.56
2008 Jacobsen MD, Boekhout T, Odds FC. Multilocus sequence typing confirms synonymy but highlights differences between Candida albicans and Candida stellatoidea. Fems Yeast Research. 8: 764-70. PMID 18547330 DOI: 10.1111/J.1567-1364.2008.00392.X  0.419
2008 Odds FC, Jacobsen MD. Multilocus sequence typing of pathogenic Candida species. Eukaryotic Cell. 7: 1075-84. PMID 18456859 DOI: 10.1128/Ec.00062-08  0.326
2008 Jacobsen MD, Davidson AD, Li SY, Shaw DJ, Gow NA, Odds FC. Molecular phylogenetic analysis of Candida tropicalis isolates by multi-locus sequence typing. Fungal Genetics and Biology : Fg & B. 45: 1040-2. PMID 18440253 DOI: 10.1016/J.Fgb.2008.03.011  0.606
2008 Naglik JR, Fidel PL, Odds FC. Animal models of mucosal Candida infection. Fems Microbiology Letters. 283: 129-39. PMID 18422625 DOI: 10.1111/J.1574-6968.2008.01160.X  0.396
2008 Strijbis K, van Roermund CW, Visser WF, Mol EC, van den Burg J, MacCallum DM, Odds FC, Paramonova E, Krom BP, Distel B. Carnitine-dependent transport of acetyl coenzyme A in Candida albicans is essential for growth on nonfermentable carbon sources and contributes to biofilm formation. Eukaryotic Cell. 7: 610-8. PMID 18281597 DOI: 10.1128/Ec.00017-08  0.76
2008 Takakura S, Ichiyama S, Bain JM, Davidson AD, Jacobsen MD, Shaw DJ, Gow NA, Odds FC. Comparison of Candida albicans strain types among isolates from three countries. International Journal of Medical Microbiology : Ijmm. 298: 663-8. PMID 18165151 DOI: 10.1016/J.Ijmm.2007.11.002  0.599
2008 Barelle CJ, Duncan VM, Brown AJ, Gow NA, Odds FC. Azole antifungals induce up-regulation of SAP4, SAP5 and SAP6 secreted proteinase genes in filamentous Candida albicans cells in vitro and in vivo. The Journal of Antimicrobial Chemotherapy. 61: 315-22. PMID 18033783 DOI: 10.1093/Jac/Dkm456  0.609
2007 Chaves GM, Bates S, Maccallum DM, Odds FC. Candida albicans GRX2, encoding a putative glutaredoxin, is required for virulence in a murine model. Genetics and Molecular Research : Gmr. 6: 1051-63. PMID 18273798  0.753
2007 Gow NA, Netea MG, Munro CA, Ferwerda G, Bates S, Mora-Montes HM, Walker L, Jansen T, Jacobs L, Tsoni V, Brown GD, Odds FC, Van der Meer JW, Brown AJ, Kullberg BJ. Immune recognition of Candida albicans beta-glucan by dectin-1. The Journal of Infectious Diseases. 196: 1565-71. PMID 18008237 DOI: 10.1086/523110  0.574
2007 Mora-Montes HM, Bates S, Netea MG, Díaz-Jiménez DF, López-Romero E, Zinker S, Ponce-Noyola P, Kullberg BJ, Brown AJ, Odds FC, Flores-Carreón A, Gow NA. Endoplasmic reticulum alpha-glycosidases of Candida albicans are required for N glycosylation, cell wall integrity, and normal host-fungus interaction. Eukaryotic Cell. 6: 2184-93. PMID 17933909 DOI: 10.1128/Ec.00350-07  0.587
2007 Brown AJ, Odds FC, Gow NA. Infection-related gene expression in Candida albicans. Current Opinion in Microbiology. 10: 307-13. PMID 17707687 DOI: 10.1016/J.Mib.2007.04.001  0.645
2007 Odds FC, Hanson MF, Davidson AD, Jacobsen MD, Wright P, Whyte JA, Gow NA, Jones BL. One year prospective survey of Candida bloodstream infections in Scotland. Journal of Medical Microbiology. 56: 1066-75. PMID 17644714 DOI: 10.1099/Jmm.0.47239-0  0.62
2007 Odds FC, Bougnoux ME, Shaw DJ, Bain JM, Davidson AD, Diogo D, Jacobsen MD, Lecomte M, Li SY, Tavanti A, Maiden MC, Gow NA, d'Enfert C. Molecular phylogenetics of Candida albicans. Eukaryotic Cell. 6: 1041-52. PMID 17416899 DOI: 10.1128/Ec.00041-07  0.585
2007 Kunze D, MacCallum D, Odds FC, Hube B. Multiple functions of DOA1 in Candida albicans. Microbiology (Reading, England). 153: 1026-41. PMID 17379712 DOI: 10.1099/Mic.0.2006/002741-0  0.771
2007 Bain JM, Tavanti A, Davidson AD, Jacobsen MD, Shaw D, Gow NA, Odds FC. Multilocus sequence typing of the pathogenic fungus Aspergillus fumigatus. Journal of Clinical Microbiology. 45: 1469-77. PMID 17376886 DOI: 10.1128/Jcm.00064-07  0.574
2007 Bates S, de la Rosa JM, MacCallum DM, Brown AJ, Gow NA, Odds FC. Candida albicans Iff11, a secreted protein required for cell wall structure and virulence. Infection and Immunity. 75: 2922-8. PMID 17371861 DOI: 10.1128/Iai.00102-07  0.813
2007 Enjalbert B, MacCallum DM, Odds FC, Brown AJ. Niche-specific activation of the oxidative stress response by the pathogenic fungus Candida albicans. Infection and Immunity. 75: 2143-51. PMID 17339352 DOI: 10.1128/Iai.01680-06  0.753
2007 Jacobsen MD, Whyte JA, Odds FC. Candida albicans and Candida dubliniensis respond differently to echinocandin antifungal agents in vitro. Antimicrobial Agents and Chemotherapy. 51: 1882-4. PMID 17307974 DOI: 10.1128/Aac.01525-06  0.311
2007 Argimón S, Wishart JA, Leng R, Macaskill S, Mavor A, Alexandris T, Nicholls S, Knight AW, Enjalbert B, Walmsley R, Odds FC, Gow NA, Brown AJ. Developmental regulation of an adhesin gene during cellular morphogenesis in the fungal pathogen Candida albicans. Eukaryotic Cell. 6: 682-92. PMID 17277173 DOI: 10.1128/Ec.00340-06  0.598
2007 Jacobsen MD, Gow NA, Maiden MC, Shaw DJ, Odds FC. Strain typing and determination of population structure of Candida krusei by multilocus sequence typing. Journal of Clinical Microbiology. 45: 317-23. PMID 17122025 DOI: 10.1128/Jcm.01549-06  0.617
2006 Odds FC, Davidson AD, Jacobsen MD, Tavanti A, Whyte JA, Kibbler CC, Ellis DH, Maiden MC, Shaw DJ, Gow NA. Candida albicans strain maintenance, replacement, and microvariation demonstrated by multilocus sequence typing. Journal of Clinical Microbiology. 44: 3647-58. PMID 17021093 DOI: 10.1128/Jcm.00934-06  0.369
2006 Piekarska K, Mol E, Van Den Berg M, Hardy G, Van Den Burg J, Van Roermund C, MacCallum D, Odds F, Distel B. Peroxisomal fatty acid β-oxidation is not essential for virulence of Candida albicans Eukaryotic Cell. 5: 1847-1856. PMID 16963628 DOI: 10.1128/Ec.00093-06  0.756
2006 MacCallum DM, Findon H, Kenny CC, Butler G, Haynes K, Odds FC. Different consequences of ACE2 and SWI5 gene disruptions for virulence of pathogenic and nonpathogenic yeasts. Infection and Immunity. 74: 5244-8. PMID 16926418 DOI: 10.1128/Iai.00817-06  0.785
2006 Chen KW, Chen YC, Lo HJ, Odds FC, Wang TH, Lin CY, Li SY. Multilocus sequence typing for analyses of clonality of Candida albicans strains in Taiwan. Journal of Clinical Microbiology. 44: 2172-8. PMID 16757617 DOI: 10.1128/Jcm.00320-06  0.382
2006 Netea MG, Gow NA, Munro CA, Bates S, Collins C, Ferwerda G, Hobson RP, Bertram G, Hughes HB, Jansen T, Jacobs L, Buurman ET, Gijzen K, Williams DL, Torensma R, ... ... Odds FC, et al. Immune sensing of Candida albicans requires cooperative recognition of mannans and glucans by lectin and Toll-like receptors. The Journal of Clinical Investigation. 116: 1642-50. PMID 16710478 DOI: 10.1172/Jci27114  0.793
2006 Barelle CJ, Priest CL, Maccallum DM, Gow NA, Odds FC, Brown AJ. Niche-specific regulation of central metabolic pathways in a fungal pathogen. Cellular Microbiology. 8: 961-71. PMID 16681837 DOI: 10.1111/J.1462-5822.2005.00676.X  0.806
2006 Albrecht A, Felk A, Pichova I, Naglik JR, Schaller M, de Groot P, Maccallum D, Odds FC, Schäfer W, Klis F, Monod M, Hube B. Glycosylphosphatidylinositol-anchored proteases of Candida albicans target proteins necessary for both cellular processes and host-pathogen interactions. The Journal of Biological Chemistry. 281: 688-94. PMID 16269404 DOI: 10.1074/Jbc.M509297200  0.77
2006 Bates S, Hughes HB, Munro CA, Thomas WP, MacCallum DM, Bertram G, Atrih A, Ferguson MA, Brown AJ, Odds FC, Gow NA. Outer chain N-glycans are required for cell wall integrity and virulence of Candida albicans. The Journal of Biological Chemistry. 281: 90-8. PMID 16263704 DOI: 10.1074/Jbc.M510360200  0.8
2005 Tavanti A, Davidson AD, Fordyce MJ, Gow NA, Maiden MC, Odds FC. Population structure and properties of Candida albicans, as determined by multilocus sequence typing. Journal of Clinical Microbiology. 43: 5601-13. PMID 16272493 DOI: 10.1128/Jcm.43.11.5601-5613.2005  0.601
2005 Tavanti A, Davidson AD, Johnson EM, Maiden MC, Shaw DJ, Gow NA, Odds FC. Multilocus sequence typing for differentiation of strains of Candida tropicalis. Journal of Clinical Microbiology. 43: 5593-600. PMID 16272492 DOI: 10.1128/Jcm.43.11.5593-5600.2005  0.589
2005 Tournu H, Tripathi G, Bertram G, Macaskill S, Mavor A, Walker L, Odds FC, Gow NA, Brown AJ. Global role of the protein kinase Gcn2 in the human pathogen Candida albicans. Eukaryotic Cell. 4: 1687-96. PMID 16215176 DOI: 10.1128/Ec.4.10.1687-1696.2005  0.614
2005 Kunze D, Melzer I, Bennett D, Sanglard D, MacCallum D, Nörskau J, Coleman DC, Odds FC, Schäfer W, Hube B. Functional analysis of the phospholipase C gene CaPLC1 and two unusual phospholipase C genes, CaPLC2 and CaPLC3, of Candida albicans. Microbiology (Reading, England). 151: 3381-94. PMID 16207920 DOI: 10.1099/Mic.0.28353-0  0.79
2005 MacCallum DM, Whyte JA, Odds FC. Efficacy of caspofungin and voriconazole combinations in experimental aspergillosis. Antimicrobial Agents and Chemotherapy. 49: 3697-701. PMID 16127042 DOI: 10.1128/Aac.49.9.3697-3701.2005  0.71
2005 Bates S, MacCallum DM, Bertram G, Munro CA, Hughes HB, Buurman ET, Brown AJ, Odds FC, Gow NA. Candida albicans Pmr1p, a secretory pathway P-type Ca2+/Mn2+-ATPase, is required for glycosylation and virulence. The Journal of Biological Chemistry. 280: 23408-15. PMID 15843378 DOI: 10.1074/Jbc.M502162200  0.804
2005 MacCallum DM, Odds FC. Temporal events in the intravenous challenge model for experimental Candida albicans infections in female mice. Mycoses. 48: 151-61. PMID 15842329 DOI: 10.1111/J.1439-0507.2005.01121.X  0.756
2005 Copping VM, Barelle CJ, Hube B, Gow NA, Brown AJ, Odds FC. Exposure of Candida albicans to antifungal agents affects expression of SAP2 and SAP9 secreted proteinase genes. The Journal of Antimicrobial Chemotherapy. 55: 645-54. PMID 15820985 DOI: 10.1093/Jac/Dki088  0.62
2005 Fradin C, De Groot P, MacCallum D, Schaller M, Klis F, Odds FC, Hube B. Granulocytes govern the transcriptional response, morphology and proliferation of Candida albicans in human blood. Molecular Microbiology. 56: 397-415. PMID 15813733 DOI: 10.1111/J.1365-2958.2005.04557.X  0.769
2005 Meerpoel L, Backx LJ, Van der Veken LJ, Heeres J, Corens D, De Groot A, Odds FC, Van Gerven F, Woestenborghs FA, Van Breda A, Oris M, van Dorsselaer P, Willemsens GH, Vermuyten KJ, Marichal PJ, et al. Synthesis and in vitro and in vivo structure-activity relationships of novel antifungal triazoles for dermatology. Journal of Medicinal Chemistry. 48: 2184-93. PMID 15771461 DOI: 10.1021/Jm0494772  0.396
2005 Tavanti A, Davidson AD, Gow NA, Maiden MC, Odds FC. Candida orthopsilosis and Candida metapsilosis spp. nov. to replace Candida parapsilosis groups II and III. Journal of Clinical Microbiology. 43: 284-92. PMID 15634984 DOI: 10.1128/Jcm.43.1.284-292.2005  0.582
2005 Munro CA, Bates S, Buurman ET, Hughes HB, Maccallum DM, Bertram G, Atrih A, Ferguson MA, Bain JM, Brand A, Hamilton S, Westwater C, Thomson LM, Brown AJ, Odds FC, et al. Mnt1p and Mnt2p of Candida albicans are partially redundant alpha-1,2-mannosyltransferases that participate in O-linked mannosylation and are required for adhesion and virulence. The Journal of Biological Chemistry. 280: 1051-60. PMID 15519997 DOI: 10.1074/Jbc.M411413200  0.794
2004 MacCallum DM, Odds FC. Need for early antifungal treatment confirmed in experimental disseminated Candida albicans infection. Antimicrobial Agents and Chemotherapy. 48: 4911-4. PMID 15561880 DOI: 10.1128/Aac.48.12.4911-4914.2004  0.73
2004 MacCallum DM, Odds FC. Safety aspects of working with Candida albicans-infected mice. Medical Mycology. 42: 305-9. PMID 15473354 DOI: 10.1080/13693780310001601092  0.747
2004 Brand A, MacCallum DM, Brown AJ, Gow NA, Odds FC. Ectopic expression of URA3 can influence the virulence phenotypes and proteome of Candida albicans but can be overcome by targeted reintegration of URA3 at the RPS10 locus. Eukaryotic Cell. 3: 900-9. PMID 15302823 DOI: 10.1128/Ec.3.4.900-909.2004  0.794
2004 Odds FC, Motyl M, Andrade R, Bille J, Cantón E, Cuenca-Estrella M, Davidson A, Durussel C, Ellis D, Foraker E, Fothergill AW, Ghannoum MA, Giacobbe RA, Gobernado M, Handke R, et al. Interlaboratory comparison of results of susceptibility testing with caspofungin against Candida and Aspergillus species. Journal of Clinical Microbiology. 42: 3475-82. PMID 15297486 DOI: 10.1128/Jcm.42.8.3475-3482.2004  0.313
2004 Galán A, Casanova M, Murgui A, MacCallum DM, Odds FC, Gow NA, Martínez JP. The Candida albicans pH-regulated KER1 gene encodes a lysine/glutamic-acid-rich plasma-membrane protein that is involved in cell aggregation. Microbiology (Reading, England). 150: 2641-51. PMID 15289560 DOI: 10.1099/Mic.0.26339-0  0.8
2004 Hobson RP, Munro CA, Bates S, MacCallum DM, Cutler JE, Heinsbroek SE, Brown GD, Odds FC, Gow NA. Loss of cell wall mannosylphosphate in Candida albicans does not influence macrophage recognition. The Journal of Biological Chemistry. 279: 39628-35. PMID 15271989 DOI: 10.1074/Jbc.M405003200  0.806
2004 Kelly MT, MacCallum DM, Clancy SD, Odds FC, Brown AJ, Butler G. The Candida albicans CaACE2 gene affects morphogenesis, adherence and virulence. Molecular Microbiology. 53: 969-83. PMID 15255906 DOI: 10.1111/J.1365-2958.2004.04185.X  0.782
2004 Odds FC, Brown AJ, Gow NA. Candida albicans genome sequence: a platform for genomics in the absence of genetics. Genome Biology. 5: 230. PMID 15239821 DOI: 10.1186/Gb-2004-5-7-230  0.57
2004 Tavanti A, Gow NA, Maiden MC, Odds FC, Shaw DJ. Genetic evidence for recombination in Candida albicans based on haplotype analysis. Fungal Genetics and Biology : Fg & B. 41: 553-62. PMID 15050544 DOI: 10.1016/J.Fgb.2003.12.008  0.577
2004 Barelle CJ, Manson CL, MacCallum DM, Odds FC, Gow NA, Brown AJ. GFP as a quantitative reporter of gene regulation in Candida albicans. Yeast (Chichester, England). 21: 333-40. PMID 15042593 DOI: 10.1002/Yea.1099  0.801
2004 Sendid B, Jouault T, Coudriau R, Camus D, Odds F, Tabouret M, Poulain D. Increased Sensitivity of Mannanemia Detection Tests by Joint Detection of α- and β-Linked Oligomannosides during Experimental and Human Systemic Candidiasis Journal of Clinical Microbiology. 42: 164-171. PMID 14715748 DOI: 10.1128/Jcm.42.1.164-171.2004  0.326
2003 Bougnoux ME, Tavanti A, Bouchier C, Gow NA, Magnier A, Davidson AD, Maiden MC, D'Enfert C, Odds FC. Collaborative consensus for optimized multilocus sequence typing of Candida albicans. Journal of Clinical Microbiology. 41: 5265-6. PMID 14605179 DOI: 10.1128/Jcm.41.11.5265-5266.2003  0.324
2003 Tavanti A, Gow NA, Senesi S, Maiden MC, Odds FC. Optimization and validation of multilocus sequence typing for Candida albicans. Journal of Clinical Microbiology. 41: 3765-76. PMID 12904388 DOI: 10.1128/Jcm.41.8.3765-3776.2003  0.597
2003 Odds FC, Brown AJ, Gow NA. Antifungal agents: mechanisms of action. Trends in Microbiology. 11: 272-9. PMID 12823944 DOI: 10.1016/S0966-842X(03)00117-3  0.538
2003 Odds FC. Reflections on the question: what does molecular mycology have to do with the clinician treating the patient? Medical Mycology. 41: 1-6. PMID 12627798 DOI: 10.1080/Mmy.41.1.1.6  0.322
2002 Freydière AM, Parant F, Noel-Baron F, Crepy M, Treny A, Raberin H, Davidson A, Odds FC. Identification of Candida glabrata by a 30-second trehalase test. Journal of Clinical Microbiology. 40: 3602-5. PMID 12354852 DOI: 10.1128/Jcm.40.10.3602-3605.2002  0.361
2002 MacCallum DM, Odds FC. Efficacy of parenteral itraconazole against disseminated Candida albicans infection in two mouse strains. The Journal of Antimicrobial Chemotherapy. 50: 225-9. PMID 12161403 DOI: 10.1093/Jac/Dkf072  0.749
2002 MacCallum DM, Odds FC. Influence of grapefruit juice on itraconazole plasma levels in mice and guinea pigs. The Journal of Antimicrobial Chemotherapy. 50: 219-24. PMID 12161402 DOI: 10.1093/Jac/Dkf103  0.735
2002 Gow NA, Brown AJ, Odds FC. Fungal morphogenesis and host invasion. Current Opinion in Microbiology. 5: 366-71. PMID 12160854 DOI: 10.1016/S1369-5274(02)00338-7  0.596
2002 Badoc C, De Meeûs T, Bertout S, Odds FC, Mallié M, Bastide JM. Clonality structure in Candida dubliniensis. Fems Microbiology Letters. 209: 249-54. PMID 12007813 DOI: 10.1111/J.1574-6968.2002.Tb11139.X  0.361
2002 Sanglard D, Odds FC. Resistance of Candida species to antifungal agents: molecular mechanisms and clinical consequences. The Lancet. Infectious Diseases. 2: 73-85. PMID 11901654 DOI: 10.1016/S1473-3099(02)00181-0  0.365
2001 Murad AM, Leng P, Straffon M, Wishart J, Macaskill S, MacCallum D, Schnell N, Talibi D, Marechal D, Tekaia F, d'Enfert C, Gaillardin C, Odds FC, Brown AJ. NRG1 represses yeast-hypha morphogenesis and hypha-specific gene expression in Candida albicans. The Embo Journal. 20: 4742-52. PMID 11532938 DOI: 10.1093/Emboj/20.17.4742  0.772
2001 Rambali B, Fernandez JA, Van Nuffel L, Woestenborghs F, Baert L, Massart DL, Odds FC. Susceptibility testing of pathogenic fungi with itraconazole: a process analysis of test variables. The Journal of Antimicrobial Chemotherapy. 48: 163-77. PMID 11481285 DOI: 10.1093/Jac/48.2.163  0.312
2001 Odds FC, Gow NA, Brown AJ. Fungal virulence studies come of age. Genome Biology. 2: REVIEWS1009. PMID 11276429 DOI: 10.1186/Gb-2001-2-3-Reviews1009  0.319
2001 Odds FC. Sordarin antifungal agents Expert Opinion On Therapeutic Patents. 11: 283-294. DOI: 10.1517/13543776.11.2.283  0.329
2000 Walsh TJ, Viviani MA, Arathoon E, Chiou C, Ghannoum M, Groll AH, Odds FC. New targets and delivery systems for antifungal therapy. Medical Mycology. 38: 335-47. PMID 11204162 DOI: 10.1080/Mmy.38.S1.335.347  0.323
2000 Odds FC, Davidson A. "Room temperature" use of CHROMagar Candida. Diagnostic Microbiology and Infectious Disease. 38: 147-50. PMID 11109012 DOI: 10.1016/S0732-8893(00)00197-8  0.357
2000 Odds FC, Oris M, Van Dorsselaer P, Van Gerven F. Activities of an intravenous formulation of itraconazole in experimental disseminated Aspergillus, Candida, and Cryptococcus infections. Antimicrobial Agents and Chemotherapy. 44: 3180-3. PMID 11036047 DOI: 10.1128/Aac.44.11.3180-3183.2000  0.308
2000 Odds FC, Van Nuffel L, Gow NA. Survival in experimental Candida albicans infections depends on inoculum growth conditions as well as animal host. Microbiology (Reading, England). 146: 1881-9. PMID 10931892 DOI: 10.1099/00221287-146-8-1881  0.629
2000 Odds FC. Pathogenic fungi in the 21st century. Trends in Microbiology. 8: 200-1. PMID 10785633 DOI: 10.1016/S0966-842X(00)01752-2  0.307
2000 De Backer MD, de Hoogt RA, Froyen G, Odds FC, Simons F, Contreras R, Luyten WH. Single allele knock-out of Candida albicans CGT1 leads to unexpected resistance to hygromycin B and elevated temperature. Microbiology (Reading, England). 146: 353-65. PMID 10708374 DOI: 10.1099/00221287-146-2-353  0.4
2000 Odds FC, Brown AJ, Gow NA. Might Candida albicans be made to mate after all? Trends in Microbiology. 8: 4-6. PMID 10637634 DOI: 10.1016/S0966-842X(99)01655-8  0.438
1999 Marichal P, Koymans L, Willemsens S, Bellens D, Verhasselt P, Luyten W, Borgers M, Ramaekers FC, Odds FC, Bossche HV. Contribution of mutations in the cytochrome P450 14alpha-demethylase (Erg11p, Cyp51p) to azole resistance in Candida albicans. Microbiology (Reading, England). 145: 2701-13. PMID 10537192 DOI: 10.1099/00221287-145-10-2701  0.359
1999 Overdijk B, Van Steijn GJ, Odds FC. Distribution of chitinase in guinea pig tissues and increases in levels of this enzyme after systemic infection with Aspergillus fumigatus. Microbiology (Reading, England). 145: 259-69. PMID 10206706 DOI: 10.1099/13500872-145-1-259  0.306
1999 Marichal P, Gorrens J, Laurijssens L, Vermuyten K, Van Hove C, Le Jeune L, Verhasselt P, Sanglard D, Borgers M, Ramaekers FCS, Odds F, Vanden Bossche H. Accumulation of 3-Ketosteroids Induced by Itraconazole in Azole-Resistant Clinical Candida albicans Isolates Antimicrobial Agents and Chemotherapy. 43: 2663-2670. DOI: 10.1128/Aac.43.11.2663  0.414
1998 Odds FC. Should resistance to azole antifungals in vitro be interpreted as predicting clinical non-response? Drug Resistance Updates : Reviews and Commentaries in Antimicrobial and Anticancer Chemotherapy. 1: 11-5. PMID 17092791 DOI: 10.1016/S1368-7646(98)80209-4  0.325
1998 Odds FC, Van Nuffel L, Dams G. Prevalence of Candida dubliniensis isolates in a yeast stock collection. Journal of Clinical Microbiology. 36: 2869-73. PMID 9738035 DOI: 10.1128/Jcm.36.10.2869-2873.1998  0.407
1998 Hube B, Sanglard D, Schaller M, Ibrahim A, Odds FC, Gow NA. [What functions do six different genes for secretory proteinases have in Candida albicans?]. Mycoses. 41: 47-50. PMID 9717386 DOI: 10.1111/J.1439-0507.1998.Tb00583.X  0.443
1998 Schoofs AG, Odds FC, Colebunders R, Ieven M, Goossens H. Cross-sectional study of oral Candida carriage in a human immunodeficiency virus (HIV)-seropositive population: predisposing factors, epidemiology and antifungal susceptibility. Mycoses. 41: 203-11. PMID 9715634 DOI: 10.1111/J.1439-0507.1998.Tb00325.X  0.314
1998 Buurman ET, Westwater C, Hube B, Brown AJ, Odds FC, Gow NA. Molecular analysis of CaMnt1p, a mannosyl transferase important for adhesion and virulence of Candida albicans. Proceedings of the National Academy of Sciences of the United States of America. 95: 7670-5. PMID 9636208 DOI: 10.1073/Pnas.95.13.7670  0.456
1998 Hube B, Rüchel R, Monod M, Sanglard D, Odds FC. Functional aspects of secreted Candida proteinases. Advances in Experimental Medicine and Biology. 436: 339-44. PMID 9561239 DOI: 10.1007/978-1-4615-5373-1_47  0.467
1998 Odds FC, Van Gerven F, Espinel-Ingroff A, Bartlett MS, Ghannoum MA, Lancaster MV, Pfaller MA, Rex JH, Rinaldi MG, Walsh TJ. Evaluation of possible correlations between antifungal susceptibilities of filamentous fungi in vitro and antifungal treatment outcomes in animal infection models. Antimicrobial Agents and Chemotherapy. 42: 282-8. PMID 9527773 DOI: 10.1128/Aac.42.2.282  0.365
1997 Odds FC. Switch of phenotype as an escape mechanism of the intruder Mycoses, Supplement. 40: 9-12. PMID 9476497 DOI: 10.1111/J.1439-0507.1997.Tb00556.X  0.412
1997 Marichal P, Vanden Bossche H, Odds FC, Nobels G, Warnock DW, Timmerman V, Van Broeckhoven C, Fay S, Mose-Larsen P. Molecular biological characterization of an azole-resistant Candida glabrata isolate. Antimicrobial Agents and Chemotherapy. 41: 2229-37. PMID 9333053 DOI: 10.1128/Aac.41.10.2229  0.319
1997 Sanglard D, Hube B, Monod M, Odds FC, Gow NA. A triple deletion of the secreted aspartyl proteinase genes SAP4, SAP5, and SAP6 of Candida albicans causes attenuated virulence. Infection and Immunity. 65: 3539-46. PMID 9284117 DOI: 10.1128/iai.65.9.3539-3546.1997  0.394
1997 Hube B, Sanglard D, Odds FC, Hess D, Monod M, Schäfer W, Brown AJ, Gow NA. Disruption of each of the secreted aspartyl proteinase genes SAP1, SAP2, and SAP3 of Candida albicans attenuates virulence. Infection and Immunity. 65: 3529-38. PMID 9284116 DOI: 10.1128/Iai.65.9.3529-3538.1997  0.457
1997 Schoofs A, Odds FC, Colebunders R, Ieven M, Wouters L, Goossens H. Isolation of Candida species on media with and without added fluconazole reveals high variability in relative growth susceptibility phenotypes. Antimicrobial Agents and Chemotherapy. 41: 1625-35. PMID 9257732 DOI: 10.1128/Aac.41.8.1625  0.342
1997 Reichard U, Monod M, Odds F, Rüchel R. Virulence of an aspergillopepsin-deficient mutant of Aspergillus fumigatus and evidence for another aspartic proteinase linked to the fungal cell wall. Journal of Medical and Veterinary Mycology : Bi-Monthly Publication of the International Society For Human and Animal Mycology. 35: 189-96. PMID 9229335 DOI: 10.1080/02681219780001131  0.421
1997 Schoofs A, Odds FC, Colebunders R, Ieven M, Goossens H. Use of specialised isolation media for recognition and identification of Candida dubliniensis isolates from HIV-infected patients European Journal of Clinical Microbiology and Infectious Diseases. 16: 296-300. PMID 9177963 DOI: 10.1007/Bf01695634  0.366
1997 Rex JH, Pfaller MA, Galgiani JN, Bartlett MS, Espinel-Ingroff A, Ghannoum MA, Lancaster M, Odds FC, Rinaldi MG, Walsh TJ, Barry AL. Development of interpretive breakpoints for antifungal susceptibility testing: conceptual framework and analysis of in vitro-in vivo correlation data for fluconazole, itraconazole, and candida infections. Subcommittee on Antifungal Susceptibility Testing of the National Committee for Clinical Laboratory Standards. Clinical Infectious Diseases : An Official Publication of the Infectious Diseases Society of America. 24: 235-47. PMID 9114154 DOI: 10.1093/Clinids/24.2.235  0.339
1997 Odds FC, Rinaldi MG, Cooper CR, Fothergill A, Pasarell L, McGinnis MR. Candida and Torulopsis: a blinded evaluation of use of pseudohypha formation as basis for identification of medically important yeasts. Journal of Clinical Microbiology. 35: 313-6. PMID 8968937 DOI: 10.1128/Jcm.35.1.313-316.1997  0.357
1996 Overdijk B, Van Steijn GJ, Odds FC. Chitinase levels in guinea pig blood are increased after systemic infection with Aspergillus fumigatus Glycobiology. 6: 627-634. PMID 8922958 DOI: 10.1093/Glycob/6.6.627  0.339
1996 Odds FC, Dams G, Just G, Lewi P. Susceptibilities of Candida spp. to antifungal agents visualized by two-dimensional scatterplots of relative growth. Antimicrobial Agents and Chemotherapy. 40: 588-94. PMID 8851576 DOI: 10.1128/Aac.40.3.588  0.356
1996 Rex JH, Pfaller MA, Lancaster M, Odds FC, Bolmstrom A, Rinaldi MG. Quality control guidelines for National Committee for Clinical Laboratory standards-recommended broth macrodilution testing of ketoconazole and itraconazole Journal of Clinical Microbiology. 34: 816-817. PMID 8815089 DOI: 10.1128/Jcm.34.4.816-817.1996  0.312
1996 Pfaller MA, Messer SA, Bolmström A, Odds FC, Rex JH. Multisite reproducibility of the Etest MIC method for antifungal susceptibility testing of yeast isolates Journal of Clinical Microbiology. 34: 1691-1693. PMID 8784571 DOI: 10.1128/Jcm.34.7.1691-1693.1996  0.388
1996 Odds FC. Epidemiological shifts in opportunistic and nosocomial Candida infections: Mycological aspects International Journal of Antimicrobial Agents. 6: 141-144. DOI: 10.1016/0924-8579(95)00049-6  0.385
1995 Odds FC, Vranckx L, Woestenborghs F. Antifungal susceptibility testing of yeasts: Evaluation of technical variables for test automation Antimicrobial Agents and Chemotherapy. 39: 2051-2060. PMID 8540715 DOI: 10.1128/Aac.39.9.2051  0.35
1994 Odds FC. Pathogenesis of Candida infections Journal of the American Academy of Dermatology. 31: S2-S5. PMID 8077502 DOI: 10.1016/S0190-9622(08)81257-1  0.423
1994 Odds FC, Bernaerts R. CHROMagar Candida, a new differential isolation medium for presumptive identification of clinically important Candida species Journal of Clinical Microbiology. 32: 1923-1929. PMID 7989544 DOI: 10.1128/Jcm.32.8.1923-1929.1994  0.404
1994 Agabian N, Odds FC, Poulain D, Soll DR, White TC. Pathogenesis of invasive candidiasis. Journal of Medical and Veterinary Mycology : Bi-Monthly Publication of the International Society For Human and Animal Mycology. 32: 229-37. PMID 7722789 DOI: 10.1080/02681219480000861  0.41
1993 Odds FC. Resistance of yeasts to azole-derivative antifungals Journal of Antimicrobial Chemotherapy. 31: 463-471. PMID 8514644 DOI: 10.1093/Jac/31.4.463  0.335
1993 Odds FC. Effects of temperature on anti-Candida activities of antifungal antibiotics Antimicrobial Agents and Chemotherapy. 37: 685-691. PMID 8494363 DOI: 10.1128/Aac.37.4.685  0.379
1993 Odds FC. Itraconazole - a new oral antifungal agent with a very broad spectrum of activity in superficial and systemic mycoses Journal of Dermatological Science. 5: 65-72. PMID 8395201 DOI: 10.1016/0923-1811(93)90072-W  0.302
1993 Odds F. Morphological Change in Candida albicans. Nippon Ishinkin Gakkai Zasshi. 34: 99-111. DOI: 10.3314/Jjmm.34.99  0.396
1992 Merson-Davies LA, Odds FC. Expansion of the Candida albicans cell envelope in different morphological forms of the fungus Journal of General Microbiology. 138: 461-466. PMID 1593260 DOI: 10.1099/00221287-138-3-461  0.333
1992 Schmid J, Odds FC, Wiselka MJ, Nicholson KG, Soll DR. Genetic similarity and maintenance of Candida albicans strains from a group of AIDS patients, demonstrated by DNA fingerprinting Journal of Clinical Microbiology. 30: 935-941. PMID 1572980 DOI: 10.1128/Jcm.30.4.935-941.1992  0.325
1992 Odds FC, Brawner DL, Staudinger J, Magee PT, Soll DR. Typing of Candida albicans strains Journal of Medical and Veterinary Mycology, Supplement. 30: 87-94. PMID 1474463 DOI: 10.1080/02681219280000801  0.332
1992 Odds FC. Antifungal susceptibility testing of Candida spp. by relative growth measurement at single concentrations of antifungal agents Antimicrobial Agents and Chemotherapy. 36: 1727-1737. PMID 1416856 DOI: 10.1128/Aac.36.8.1727  0.396
1992 Xhonneux B, Jansen T, Borgers M, Odds FC. Effects of itraconazole on phagocytosis and killing of Candida glabrata by polymorphonuclear leucocytes from guinea pigs Journal of Antimicrobial Chemotherapy. 30: 181-188. PMID 1328134 DOI: 10.1093/Jac/30.2.181  0.37
1991 Hube B, Turver CJ, Odds FC, Eiffert H, Boulnois GJ, Kockel H, Ruchel R. Sequence of the Candida albicans gene encoding the secretory aspartate proteinase Journal of Medical and Veterinary Mycology. 29: 129-132. PMID 1880680 DOI: 10.1080/02681219180000221  0.314
1991 Odds FC. Long-term laboratory preservation of pathogenic yeasts in water Journal of Medical and Veterinary Mycology. 29: 413-415. PMID 1815033 DOI: 10.1080/02681219180000651  0.305
1991 Merson-Davies LA, Odds FC, Malet R, Young S, Riley V, Schober P, Fisk PG. Quantification of Candida albicans morphology in vaginal smears European Journal of Obstetrics and Gynecology and Reproductive Biology. 42: 49-52. PMID 1778291 DOI: 10.1016/0028-2243(91)90159-I  0.329
1991 Odds FC. Quantitative microculture system with standardized inocula for strain typing, susceptibility testing, and other physiologic measurements with Candida albicans and other yeasts Journal of Clinical Microbiology. 29: 2735-2740. PMID 1757542 DOI: 10.1128/Jcm.29.12.2735-2740.1991  0.367
1991 Merson-Davies LA, Hopwood V, Robert R, Marot-Leblond A, Senet JM, Odds FC. Reaction of Candida albicans cells of different morphology index with monoclonal antibodies specific for the hyphal form Journal of Medical Microbiology. 35: 321-324. PMID 1753389 DOI: 10.1099/00222615-35-6-321  0.369
1991 Mackenzie DWR, Odds FC. Non-identity and authentication of two major reference strains of Candida albicans Journal of Medical and Veterinary Mycology. 29: 255-261. PMID 1682436 DOI: 10.1080/02681219180000371  0.33
1991 Cutsem JV, Gerven FV, Cauwenbergh G, Odds F, Janssen PA. The antiinflammatory effects of ketoconazole Journal of the American Academy of Dermatology. 25: 257-261. DOI: 10.1016/0190-9622(91)70192-5  0.334
1990 Merson-Davies LA, Odds FC. A morphology index for characterization of cell shape in Candida albicans. Journal of General Microbiology. 135: 3143-52. PMID 2693594 DOI: 10.1099/00221287-135-11-3143  0.404
1990 Odds FC, Kibbler CC, Walker E, Bhamra A, Prentice HG, Noone P. Carriage of Candida species and C albicans biotypes in patients undergoing chemotherapy or bone marrow transplantation for haematological disease. Journal of Clinical Pathology. 42: 1259-66. PMID 2693492 DOI: 10.1136/Jcp.42.12.1259  0.361
1990 Odds FC. Antifungal activity of saperconazole (R 66 905) in vitro. The Journal of Antimicrobial Chemotherapy. 24: 533-7. PMID 2613602 DOI: 10.1093/Jac/24.4.533  0.329
1990 Pfaller MA, Rinaldi MG, Galgiani JN, Bartlett MS, Body BA, Espinel-Ingroff A, Fromtling RA, Hall GS, Hughes CE, Odds FC. Collaborative investigation of variables in susceptibility testing of yeasts. Antimicrobial Agents and Chemotherapy. 34: 1648-54. PMID 2285276 DOI: 10.1128/Aac.34.9.1648  0.352
1990 Fruit J, Cailliez JC, Odds FC, Poulain D. Expression of an epitope by surface glycoproteins of Candida albicans. Variability among species, strains and yeast cells of the genus Candida. Journal of Medical and Veterinary Mycology : Bi-Monthly Publication of the International Society For Human and Animal Mycology. 28: 241-52. PMID 1698961 DOI: 10.1080/02681219080000301  0.405
1989 Odds FC. Activity of cilofungin (LY121019) against Candida species in vitro. The Journal of Antimicrobial Chemotherapy. 22: 891-7. PMID 3243737 DOI: 10.1093/Jac/22.6.891  0.375
1989 Page S, Odds FC. Binding of plasma proteins to Candida species in vitro. Journal of General Microbiology. 134: 2693-702. PMID 3076172 DOI: 10.1099/00221287-134-10-2693  0.367
1989 Odds FC, Merson-Davies LA. Colony variations in Candida species. Mycoses. 32: 275-82. PMID 2674711 DOI: 10.1111/J.1439-0507.1989.Tb02245.X  0.377
1989 Odds FC, Auger P, Krogh P, Neely AN, Segal E. Biotyping of Candida albicans: results of an international collaborative survey. Journal of Clinical Microbiology. 27: 1506-9. PMID 2671015 DOI: 10.1128/Jcm.27.7.1506-1509.1989  0.302
1989 Odds FC, Webster CE, Fisk PG, Riley VC, Mayuranathan P, Simmons PD. Candida species and C. albicans biotypes in women attending clinics in genitourinary medicine. Journal of Medical Microbiology. 29: 51-4. PMID 2657069 DOI: 10.1099/00222615-29-1-51  0.344
1988 Odds FC. Candida infections: an overview. Critical Reviews in Microbiology. 15: 1-5. PMID 3319417 DOI: 10.3109/10408418709104444  0.393
1988 Neely AN, Odds FC, Basatia BK, Holder IA. Characterization of Candida isolates from pediatric burn patients. Journal of Clinical Microbiology. 26: 1645-9. PMID 3053771 DOI: 10.1128/Jcm.26.9.1645-1649.1988  0.422
1988 Odds FC, Webster CE. Effects of azole antifungals in vitro on host/parasite interactions relevant to Candida infections. The Journal of Antimicrobial Chemotherapy. 22: 473-81. PMID 2849601 DOI: 10.1093/Jac/22.4.473  0.42
1987 Odds FC, Webster CE, Riley VC, Fisk PG. Epidemiology of vaginal Candida infection: significance of numbers of vaginal yeasts and their biotypes. European Journal of Obstetrics, Gynecology, and Reproductive Biology. 25: 53-66. PMID 3297841 DOI: 10.1097/00006254-198711000-00019  0.356
1987 Odds FC, Palacio-Hernanz A, Cuadra J, Sanchéz J. Disseminated Candida infection syndrome in heroin addicts--dominance of a single Candida albicans biotype. Journal of Medical Microbiology. 23: 275-7. PMID 3295247 DOI: 10.1099/00222615-23-3-275  0.413
1987 Webster C, Odds F. Growth of pathogenicCandidaisolates anaerobically and under elevated concentrations of CO2in air Medical Mycology. 25: 47-53. DOI: 10.1080/02681218780000061  0.387
1986 Odds FC. Candida albicans proteinase as a virulence factor in the pathogenesis of Candida infections. Zentralblatt Fur Bakteriologie, Mikrobiologie, Und Hygiene. Series a, Medical Microbiology, Infectious Diseases, Virology, Parasitology. 260: 539-42. PMID 3914794 DOI: 10.1016/S0176-6724(85)80069-9  0.36
1986 Anderson ML, Odds FC. Adherence of Candida albicans to vaginal epithelia: significance of morphological form and effect of ketoconazole. Mykosen. 28: 531-40. PMID 3908931 DOI: 10.1111/J.1439-0507.1985.Tb02083.X  0.371
1986 Odds FC, Abbott AB, Pye G, Troke PF. Improved method for estimation of azole antifungal inhibitory concentrations against Candida species, based on azole/antibiotic interactions. Journal of Medical and Veterinary Mycology : Bi-Monthly Publication of the International Society For Human and Animal Mycology. 24: 305-11. PMID 3746584 DOI: 10.1080/02681218680000461  0.313
1986 Odds FC, Cheesman SL, Abbott AB. Antifungal effects of fluconazole (UK 49858), a new triazole antifungal, in vitro. The Journal of Antimicrobial Chemotherapy. 18: 473-8. PMID 3021710 DOI: 10.1093/Jac/18.4.473  0.338
1985 Burnie JP, Odds FC, Lee W, Webster C, Williams JD. Outbreak of systemic Candida albicans in intensive care unit caused by cross infection. British Medical Journal (Clinical Research Ed.). 290: 746-8. PMID 3918738 DOI: 10.1136/Bmj.290.6470.746  0.331
1985 Polak A, Odds FC, Lüdin E, Scholer HJ. Correlation of susceptibility test results in vitro with response in vivo: ketoconazole therapy in a systemic candidiasis model. Chemotherapy. 31: 395-404. PMID 3902391 DOI: 10.1159/000238365  0.377
1985 Odds FC. Morphogenesis in Candida albicans. Critical Reviews in Microbiology. 12: 45-93. PMID 3893894 DOI: 10.3109/10408418509104425  0.383
1985 Odds FC, Cockayne A, Hayward J, Abbott AB. Effects of imidazole- and triazole-derivative antifungal compounds on the growth and morphological development of Candida albicans hyphae. Journal of General Microbiology. 131: 2581-9. PMID 2999296 DOI: 10.1099/00221287-131-10-2581  0.331
1984 Odds FC, Abbott AB. Relative inhibition factors--a novel approach to the assessment of antifungal antibiotics in vitro. The Journal of Antimicrobial Chemotherapy. 13: 31-43. PMID 6698909 DOI: 10.1093/Jac/13.1.31  0.319
1984 Odds F. Demonstration of a septal pore in buddingCandida albicansyeast cells Medical Mycology. 22: 505-507. DOI: 10.1080/00362178485380791  0.351
1984 Odds F. Ecology and Epidemiology of Candida Species Zentralblatt FüR Bakteriologie, Mikrobiologie Und Hygiene. 1. Abt. Originale. a, Medizinische Mikrobiologie, Infektionskrankheiten Und Parasitologie. 257: 207-212. DOI: 10.1016/S0174-3031(84)80073-6  0.438
1983 Odds FC, Abbott AB, Reed TA, Willmott FE. Candida albicans strain types from the genitalia of patients with and without Candida infection. European Journal of Obstetrics, Gynecology, and Reproductive Biology. 15: 37-43. PMID 6350074 DOI: 10.1016/0028-2243(83)90295-2  0.406
1983 Odds FC, Abbott AB. Modification and extension of tests for differentiation of Candida species and strains. Sabouraudia. 21: 79-81. PMID 6342177 DOI: 10.1080/00362178385380111  0.315
1983 Macdonald F, Odds FC. Virulence for mice of a proteinase-secreting strain of Candida albicans and a proteinase-deficient mutant. Journal of General Microbiology. 129: 431-8. PMID 6341508 DOI: 10.1099/00221287-129-2-431  0.423
1983 Odds FC. Interactions among amphotericin B, 5-fluorocytosine, ketoconazole, and miconazole against pathogenic fungi in vitro. Antimicrobial Agents and Chemotherapy. 22: 763-70. PMID 6295266 DOI: 10.1128/Aac.22.5.763  0.311
1983 Odds FC, Abbott AB, Stiller RL, Scholer HJ, Polak A, Stevens DA. Analysis of Candida albicans phenotypes from different geographical and anatomical sources. Journal of Clinical Microbiology. 18: 849-857. DOI: 10.1128/Jcm.18.4.849-857.1983  0.365
1980 Odds F, Abbott A. A simple system for the presumptive identification ofCandida albicansand differentiation of strains within the species Medical Mycology. 18: 301-317. DOI: 10.1080/00362178085380511  0.342
1979 Odds FC, Hall CA, Abbott AB. Peptones and mycological reproducibility. Sabouraudia. 16: 237-46. PMID 36674 DOI: 10.1080/00362177885380341  0.327
1975 Evans EG, Odds FC, Richardson MD, Holland KT. Optimum conditions for initiation of filamentation in Candida albicans. Canadian Journal of Microbiology. 21: 338-42. PMID 234785 DOI: 10.1139/M75-048  0.337
1974 Evans EG, Odds FC, Richardson MD, Holland KT. The effect of growth medium of filament production in Candida albicans. Sabouraudia. 12: 112-9. PMID 4601234 DOI: 10.1080/00362177485380151  0.341
1973 Chattaway FW, Bishop R, Holmes MR, Odds FC, Barlow AJ. Enzyme activities associated with carbohydrate synthesis and breakdown in the yeast and mycelial forms of Candida albicans. Journal of General Microbiology. 75: 97-109. PMID 4269159 DOI: 10.1099/00221287-75-1-97  0.318
1972 Chattaway FW, Odds FC, Barlow AJ. An examination of the production of hydrolytic enzymes and toxins by pathogenic strains of Candida albicans. Journal of General Microbiology. 67: 255-63. PMID 5137675 DOI: 10.1099/00221287-67-3-255  0.355
Show low-probability matches.